Placebo News and Research

RSS

Combination therapy regimen for cystic fibrosis is also beneficial to primary school-aged children

Cystic fibrosis remains an incurable genetic disorder which impairs lung function and significantly reduces life expectancy.

8 Aug 2022

Trial evaluates sugemalimab as a consolidation treatment in patients with unresectable stage III NSCLC

The human monoclonal antibody sugemalimab is a safe and effective consolidation therapy for patients with unresectable stage III non-small cell lung cancer without disease progression after either concurrent chemoradiotherapy (cCRT) or sequential chemoradiotherapy (sCRT), according to findings presented today at the IASLC World Conference on Lung Cancer 2022 in Vienna.

8 Aug 2022

Inhaled aprotinin found to reduce viral load in mild-to-moderate COVID-19

A recent paper describes the use of aprotinin, a protease inhibitor that works across several pathways, to reduce the severity of COVID-19.

8 Aug 2022

The safety and preliminary efficacy of OP-101 in patients with severe COVID-19

Researchers assessed the impact of dendrimer nanotherapy in treating severe COVID-19.

8 Aug 2022

Varenicline and cytisine not more efficacious than nicotine to treat risky drinking and smoking, study says

A clinical trial to test whether three proven smoking cessation treatments could also reduce alcohol intake found no differences between the medications, but the rates of behavior change for alcohol consumption and smoking were high in all treatment groups. Results suggest these medications could play an important role to reduce alcohol use and smoking at the same time. Unexpectedly, nicotine replacement therapy performed as well as the prescription drugs varenicline and cytisine.

8 Aug 2022

Benefits of tocolytics outweigh any risks linked with unwanted side effects, study finds

Women around the world should be able to access the best medical treatments that help to delay preterm births and improve neonatal outcomes, new research suggests.

5 Aug 2022

What is the viral rebound in untreated COVID-19 infections?

Researchers assessed the coronavirus disease 2019 (COVID-19) rebound in untreated COVID-19 infections.

4 Aug 2022

Can high-dose coenzyme Q10 reduce the number and severity of post-COVID-19 condition-related symptoms?

Investigators assessed the potential of high-dose coenzyme Q10 treatment for long coronavirus disease.

4 Aug 2022

A combined influenza and COVID-19 mRNA vaccine

A combined mRNA vaccine is capable of inducing broad and durable protection against co-infection with SARS-CoV-2 and IAV,

3 Aug 2022

New treatment gives hope for people challenged with chronic back pain

People challenged with chronic back pain have been given hope with a new treatment that focuses on retraining how the back and the brain communicate, a randomized controlled trial run by researchers at UNSW Sydney and Neuroscience Research Australia and several other Australian and European universities has shown.

2 Aug 2022

Study suggests possible benefit from melatonin in COVID-19

A new study discusses the utility of vitamin C and melatonin as potentially therapeutic and capable of preventing acute lung injury in COVID-19.

1 Aug 2022

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

With this approval, RINVOQ® is the first and only Janus Kinase inhibitor approved to treat patients across the spectrum of axial spondyloarthritis (nr-axSpA and ankylosing spondylitis) in the EU.

From AbbVie 29 Jul 2022

Placebo News and Research

Combination therapy regimen for cystic fibrosis is also beneficial to primary school-aged children

Trial evaluates sugemalimab as a consolidation treatment in patients with unresectable stage III NSCLC

Inhaled aprotinin found to reduce viral load in mild-to-moderate COVID-19

The safety and preliminary efficacy of OP-101 in patients with severe COVID-19

Varenicline and cytisine not more efficacious than nicotine to treat risky drinking and smoking, study says

Benefits of tocolytics outweigh any risks linked with unwanted side effects, study finds

What is the viral rebound in untreated COVID-19 infections?

Can high-dose coenzyme Q10 reduce the number and severity of post-COVID-19 condition-related symptoms?

A combined influenza and COVID-19 mRNA vaccine

New treatment gives hope for people challenged with chronic back pain

Study suggests possible benefit from melatonin in COVID-19

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

The effect of Artemisia annua hot water extracts against the SARS-CoV-2 Omicron variant

Everything you need to know about Paxlovid — especially, should you take it?

Study finds molnupiravir well-tolerated, and effective in vaccinated and unvaccinated

Cocoa reduces blood pressure and arterial stiffness, study finds

Green tea extract consumption can reduce blood sugar levels and improve gut health

High-dose supplementation of Vitamin B6 decreases anxiety

Phase 2a clinical trial describes safety and efficacy of dendrimer nanotherapy in severe COVID-19 patients

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News